Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kimia Biosciences has informed the stock exchange that its trading window will be closed from 1st April 2026 until 48 hours after the declaration of audited financial results for the quarter and financial year ending 31st March 2026. The closure is being implemented as required under SEBI's Insider Trading Regulations, 2015. Promoters, directors, connected persons, designated persons, and their immediate relatives have been barred from trading in the company's shares during this period. The exact date of the board meeting to approve the audited results has not yet been announced.
This is a routine compliance announcement and not a negative signal on its own. However, investors should expect the company's FY26 audited results to be declared in the coming weeks, which could be a key catalyst for the stock. No insider buying or selling activity is indicated by this filing.